Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
2021 · BMC Cancer · 23 citations
https://doi.org/10.1186/s12885-020-07722-3